PNC Financial Services Group
MBX icon

PNC Financial Services Group’s MBX Biosciences MBX Stock Holding History

PNC Financial Services Group’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.7K Buy
217
+10
+5% +$626 ﹤0.01% 4064
2026
Q2 		$11.4K Hold
207
– – ﹤0.01% 4028
2026
Q1 		$6.18K Buy
207
+11
+6% +$374 ﹤0.01% 4169
2025
Q4 		$6.18K Sell
196
-56
-22% -$1.36K ﹤0.01% 4148
2025
Q3 		$4.41K Buy
+252
New +$3.37K ﹤0.01% 4250

Other funds holding MBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

PNC Financial Services Group's MBX Position: Q3 2026 in Review

PNC Financial Services Group increased its MBX Biosciences (MBX) stake by 4.8% in Q3 2026, buying an estimated $626 and bringing the position to 217 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4064.

PNC Financial Services Group first reported a position in MBX in Q3 2025 and has held it in 5 quarters since. 78 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • PNC Financial Services Group held 217 shares of MBX Biosciences worth $12.7K as of Q3 2026.
  • PNC Financial Services Group bought 10 MBX Biosciences shares in Q3 2026, an estimated $626.
  • MBX Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4064 holding.
  • PNC Financial Services Group first reported a position in MBX Biosciences in Q3 2025 and has held it in 5 quarters since.
  • 78 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.